DNA from bacteria has stimulatory effects on mammalian immune cells(1-3), w
hich depend on the presence of unmethylated CpG dinucleotides in the bacter
ial DNA. In contrast, mammalian DNA has a low frequency of CpG dinucleotide
s, and these are mostly methylated; therefore, mammalian DNA does not have
immuno-stimulatory activity. CpG DNA induces a strong T-helper-1-like infla
mmatory response(4-7). Accumulating evidence has revealed the therapeutic p
otential of CpG DNA as adjuvants for vaccination strategies for cancer, all
ergy and infectious diseases(8-10). Despite its promising clinical use, the
molecular mechanism by which CpG DNA activates immune cells remains unclea
r. Here we show that cellular response to CpG DNA is mediated by a Toll-lik
e receptor, TLR9. TLR9-deficient (TLR9(-/-)) mice did not show any response
to CpG DNA, including proliferation of splenocytes, inflammatory cytokine
production from macrophages and maturation of dendritic cells. TLR9(-/-) mi
ce showed resistance to the lethal effect of CpG DNA without any elevation
of serum pro-inflammatory cytokine levels. The in vivo CpG-DNA-mediated T-h
elper type-1 response was also abolished in TLR9(-/-) mice. Thus, vertebrat
e immune systems appear to have evolved a specific Toll-like receptor that
distinguishes bacterial DNA from self-DNA.